Cargando…

Tolvaptan

Hyponatremia is a common and often under-recogonised clinical problem in oncologic practice. The recogonition of the cause of hyponatremia and initiation of appropriate and timely intervention can prevent morbidity and improve treatment tolerance. This drug review aims at discussing the currently ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rangarajan, Bharath, Binoy, Vineetha, Hingmire, Sachin Sharatchandra, Noronha, Vanita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Drug Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134612/ https://www.ncbi.nlm.nih.gov/pubmed/25136528 http://dx.doi.org/10.4103/2278-330X.136811

Ejemplares similares

Adjuvant chemotherapy in carcinoma colon: Is there a rationale to change practice for Asian patients?
por: Rangarajan, Bharath, et al.
Publicado: (2013)

Crizotinib: A comprehensive review
por: Sahu, Arvind, et al.
Publicado: (2013)

Fixed drug eruption to fluconazole: A case report and review of literature
por: Pai, Varadraj V., et al.
Publicado: (2012)

Lamotrigine induced DRESS syndrome
por: Naveen, Kikkeri Narayanasetty, et al.
Publicado: (2012)

Breast cancer: An overview of published Indian data
por: Rangarajan, Bharath, et al.
Publicado: (2016)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

V2 Receptor Antagonist; Tolvaptan
por: Yi, Joo-Hark, et al.
Publicado: (2011)

Anti-VEGF drugs in the prevention of blindness
por: Yorston, David
Publicado: (2014)

Anti-VEGF treatment for acute ROP – not yet recommended!
por: Gilbert, Clare
Publicado: (2014)

The Situation of Chemokine Ligands and Receptors Gene Expression, Following the Oral Administration of Drug Mannuronic Acid in Rheumatoid Arthritis Patients
por: Aslani, Mona, et al.
Publicado: (2020)

Chitinases: Therapeutic Scaffolds for Allergy and Inflammation
por: Madan, Kirtika, et al.
Publicado: (2020)

Onychomycosis: An Updated Review
por: Leung, Alexander K.C., et al.
Publicado: (2020)

Anti-Inflammatory and Gastroprotective Properties of Aspirin - Entrapped Solid Lipid Microparticles
por: Chime, Salome A., et al.
Publicado: (2020)

Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
por: Lee, Hao‐Wei, et al.
Publicado: (2022)

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function
por: Moore, Kenneth T, et al.
Publicado: (2014)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Review of Tolvaptan’s Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions
por: Bhatt, Purav R., et al.
Publicado: (2014)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
por: Adachi, Takuya, et al.
Publicado: (2021)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
por: Murugusundram, Sundaram
Publicado: (2009)

Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature
por: Jain, Shreepal, et al.
Publicado: (2010)

Denosumab: A comprehensive review
por: Narayanan, Prasad
Publicado: (2013)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
por: Raut, Lalit S.
Publicado: (2015)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
por: Kirschner-Hermanns, Ruth, et al.
Publicado: (2019)

Angiotensin Receptor and Neprylisin Inhibitor: A new drug in pediatric cardiologist's armamentarium
por: Arya, Adhi, et al.
Publicado: (2020)

Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

The management of polycystic liver disease by tolvaptan
por: Takenaka, Tsuneo, et al.
Publicado: (2020)

Tolvaptan for the Treatment of Elephantiasis Nostras Verrucosa
por: Eda, Yuko, et al.
Publicado: (2019)

Management of hyponatremia associated with acute porphyria—proposal for the use of tolvaptan
por: Solares, Isabel, et al.
Publicado: (2020)

Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
por: Hingmire, Sachin S., et al.
Publicado: (2017)

Safety Profile of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
por: Bellos, Ioannis
Publicado: (2021)

Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
por: Tanabe, Norikazu, et al.
Publicado: (2017)

Open-label observational study to assess the efficacy and safety of aprepitant for chemotherapy-induced nausea and vomiting prophylaxis in Indian patients receiving chemotherapy with highly emetogenic chemotherapy/moderately emetogenic chemotherapy regimens
por: Hingmire, Sachin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ljgkl6beh405rt3q65p31vfmnj